Fortive Gestion
Gestion contrôle des critères 3/4
Le PDG Fortive est Olumide Soroye, nommé en Jun2025, a un mandat de moins d'un an. La rémunération annuelle totale est $ 8.06M, composée du salaire de 9.5% et des bonus 90.5%, y compris les actions et options de la société. détient directement 0.085% des actions de la société, d'une valeur de $ 15.23M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.3 ans et 5.2 ans.
Informations clés
Olumide Soroye
Directeur général
US$8.1m
Rémunération totale
| Pourcentage du salaire du PDG | 9.48% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 0.08% |
| Durée moyenne d'occupation des postes de direction | 1.3yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 5.2yrs |
Mises à jour récentes de la gestion
Recent updates
FTV: Sterilization Demand And Buybacks Will Support Future Earnings Quality
Fortive's analyst fair value estimate has been nudged up by $1 to $73 after analysts weighed a mix of recent price target increases and trims alongside recalibrated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Fortive shows a mix of target price trims and increases, with bullish analysts generally leaning toward higher fair value assumptions even as some recalibrate their models.
FTV: Future P E Compression Will Challenge Buyback Support At Current Levels
Fortive's analyst price targets have seen a mixed reset, with one firm trimming its view by $7 while several others lifted their targets by $4 to $9, as analysts factor in modest tweaks to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Recent research on Fortive shows a mix of optimism and caution, with several firms lifting their price targets and one trimming its view by $7.Fortive: Starting To Improve Its Performance
Apr 14FTV: Fair Value View Balances Buybacks Against Execution And P E Compression Risks
Analysts have nudged their fair value estimate for Fortive higher to $52.50 from $51.10, reflecting updated views on revenue growth, margins, and future P/E assumptions following a mix of recent price target hikes and one downgrade across the Street. Analyst Commentary Recent Street research on Fortive shows a mixed but generally cautious tone, with a cluster of price target increases alongside at least one downgrade and a later price target cut.FTV: Fair Value Case Weighs Buybacks Against Execution And Multiple Compression Risks
Fortive's analyst price target has been adjusted slightly lower to $51.10. Analysts point to updated fair value estimates, refined discount rate assumptions, and refreshed views on revenue growth, margins, and future P/E multiples following a series of recent price target revisions across major firms.FTV: North American Sterilization Demand Will Support Future Earnings Quality Upside
Analysts have lifted their price targets on Fortive, supporting a move in our fair value estimate from $66.00 to $72.00. They cited updated expectations for revenue growth, profitability and a lower forward P/E multiple.
FTV: Recent Rating Shift And Buybacks Will Shape Future Return Profile
Our updated Fortive narrative reflects a higher implied price target of about $62, as analysts factor in steadier revenue growth assumptions, slightly stronger profit margins, a modestly lower discount rate, and a similar forward P/E, consistent with a series of recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of higher Fortive price targets, alongside at least one downgrade.FTV: JPMorgan Downgrade And Buybacks Will Shape A Measured Return Profile
Analysts have trimmed their price target on Fortive to US$58.13, citing a slightly lower discount rate, modestly softer revenue expectations and a higher assumed profit margin supported by a reduced future P/E multiple. Analyst Commentary Recent commentary around the new US$58.13 price target reflects a mixed view on Fortive, with the latest JPMorgan downgrade underlining both execution opportunities and areas of concern for valuation and growth.FTV: Balanced Outlook As Healthcare Demand And Buybacks Shape Future Returns
Narrative Update The analyst price target for Fortive has shifted from approximately $56.13 to $58.13, as analysts cite recent model updates and sequential improvements in North American demand for sterilization and biomedical equipment, along with higher AHS adjusted EBITDA driven by gross profit growth and lower costs. Analyst Commentary Recent research on Fortive reflects a mix of optimism on execution and caution around upside potential, which is showing up in both price target changes and rating shifts.FTV: Fair Value View Balances Higher Demand With Margin Execution Risks
Analysts have increased their fair value estimate for Fortive from US$50.00 to US$52.00, citing refreshed models after the Q3 report and Street research that points to improved North American demand for sterilization and biomedical equipment, stronger AHS adjusted EBITDA margins, and updated price targets clustered around US$55 to US$58. Analyst Commentary Recent Street research on Fortive points to updated price targets clustered in the US$55 to US$58 range, with analysts revising their models following the Q3 report.Estimating The Fair Value Of Fortive Corporation (NYSE:FTV)
Dec 27
FTV: North American Sterilization Demand Will Support Earnings Quality And Upside Potential
Analysts have modestly raised their blended price target on Fortive to about $58 per share from roughly $55, citing improved North American demand for sterilization and biomedical equipment, stronger margins in Advanced Healthcare Solutions, and updated post earnings financial models that still reflect slightly softer long term growth and profitability assumptions. Analyst Commentary Bullish analysts are pointing to a constructive risk reward profile for Fortive, highlighting that incremental execution gains and healthier end market trends can support the recent step up in valuation.Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered their fair value estimate for Fortive to $56.13 from $57.25. They cite a tougher outlook and more challenging revenue growth projections for the remainder of the year.Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive's price target to $57.25 due to skepticism over the company's ability to meet guidance amid slowing growth in its strongest segment, caution around macro headwinds post-Ralliant spinoff, and minimal near-term revenue growth. Analyst Commentary Persistent skepticism regarding Fortive's ability to achieve its full-year guidance following a cautious update and lack of supportive industry data.Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive’s target price to $60.50, citing uncertainty about achieving updated guidance following the Ralliant spin-off, ongoing topline and margin pressures, and diminished visibility post-restructuring. Analyst Commentary Bullish analysts highlight Fortive's high earnings visibility and strong recurring revenue profile (~50%+), expecting portfolio reviews and strategic focus on workflow management software and healthcare to support margin resilience.A Look At The Intrinsic Value Of Fortive Corporation (NYSE:FTV)
May 30Fortive Seeing Signs Of Improvement, But Valuation Doesn't Make It An Easy Call
Mar 10Fortive Corporation: Undervaluation And Stability Give It An Edge (Rating Upgrade)
Dec 11Fortive: A Softer Performance Triggers A Separation
Sep 22Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Apr 03 2026 | n/a | n/a | US$557m |
| Dec 31 2025 | n/a | n/a | US$533m |
| Sep 26 2025 | n/a | n/a | US$885m |
| Jun 27 2025 | n/a | n/a | US$879m |
| Mar 28 2025 | n/a | n/a | US$388m |
| Dec 31 2024 | US$8m | US$764k | US$483m |
| Sep 27 2024 | n/a | n/a | US$555m |
| Jun 28 2024 | n/a | n/a | US$661m |
| Mar 29 2024 | n/a | n/a | US$900m |
| Dec 31 2023 | US$8m | US$750k | US$408m |
| Sep 29 2023 | n/a | n/a | US$828m |
| Jun 30 2023 | n/a | n/a | US$800m |
| Mar 31 2023 | n/a | n/a | US$764m |
| Dec 31 2022 | US$7m | US$750k | US$755m |
| Sep 30 2022 | n/a | n/a | US$696m |
| Jul 01 2022 | n/a | n/a | US$659m |
| Apr 01 2022 | n/a | n/a | US$650m |
| Dec 31 2021 | US$14m | US$274k | US$580m |
Rémunération vs marché: La rémunération totale de Olumide ($USD 8.06M ) est inférieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 14.60M ).
Rémunération et revenus: La rémunération de Olumide a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Olumide Soroye (52 yo)
Mr. Olumide O. Soroye is President, CEO & Director of Fortive Corporation from June 28, 2025. Mr. Soroye serves as Indpendent Director of Verisk Analytics, Inc. since August 19 2022. He was President and C...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | less than a year | US$8.06m | 0.085% $ 15.2m | |
| Senior VP & CFO | 1.2yrs | pas de données | 0.045% $ 8.2m | |
| Chief Accounting Officer | 6.6yrs | pas de données | 0.023% $ 4.1m | |
| Senior VP & Chief Technology and Business System Officer | 1.2yrs | pas de données | pas de données | |
| Vice President of Investor Relations | no data | pas de données | pas de données | |
| Senior VP & Chief Legal Officer | 10yrs | US$2.77m | 0.029% $ 5.2m | |
| Senior VP & Chief People Officer | less than a year | pas de données | pas de données | |
| President of Fluke & Group President of Connected Reliability Group (CRG) | no data | pas de données | pas de données | |
| President of Gordian and Group President of Facilities & Asset Lifecycle (FAL) Group | no data | pas de données | pas de données | |
| President of ASP & Group President of Infection Prevention Group (IPG) | 1.3yrs | pas de données | pas de données | |
| President of Provation & Group President of Healthcare Productivity and Quality (HPQ) Group | 1.3yrs | pas de données | pas de données | |
| Group President of Environmental | 1.3yrs | pas de données | pas de données |
Gestion expérimentée: L'équipe de direction de FTV n'est pas considérée comme expérimentée (ancienneté moyenne 1.3 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | less than a year | US$8.06m | 0.085% $ 15.2m | |
| Independent Director | 9.8yrs | US$347.98k | 0.0017% $ 300.5k | |
| Independent Director | 5.2yrs | US$326.12k | 0.013% $ 2.3m | |
| Independent Director | 7.3yrs | US$341.12k | 0.0014% $ 251.9k | |
| Independent Director | 3.3yrs | US$325.87k | 0.0015% $ 264.5k | |
| Independent Director | 4.3yrs | US$311.64k | 0.0028% $ 509.3k | |
| Independent Director | 5.4yrs | US$330.87k | 0.0014% $ 251.9k | |
| Independent Chair of the Board | 5.8yrs | US$321.13k | 0.0014% $ 251.9k | |
| Independent Director | 1.3yrs | pas de données | pas de données |
Conseil d'administration expérimenté: Les membres du conseil d'administration de FTV sont considérés comme expérimentés (ancienneté moyenne 5.2 ans).
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/03 21:51 |
| Cours de l'action en fin de journée | 2026/05/01 00:00 |
| Les revenus | 2026/04/03 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Fortive Corporation est couverte par 28 analystes. 15 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| John Eade | Argus Research Company |
| Quinn Fredrickson | Baird |
| Robert Mason | Baird |